Keyphrases
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
22%
Antifibrotic
23%
Beneficial Effects
18%
Bevacizumab
39%
Bleb Fibrosis
24%
Cell Proliferation
17%
Conjunctival
28%
Curcumin
25%
Dry Eye
25%
Epidermal Growth Factor
16%
Extracellular Matrix
18%
Factor Level
16%
Fibrin Glue
100%
Fibrosis
40%
Glaucoma
19%
Glaucomatous
17%
Growth Factors
31%
Human Pterygium Fibroblasts
25%
Human Tenon Fibroblast
37%
Immunohistochemistry
16%
Inflammation
23%
Injury Model
25%
Intracameral Injection
25%
Intravitreal
27%
Intravitreal Ranibizumab
15%
Ischemia-reperfusion Injury
25%
Limbal Stem Cells
37%
Matrix metalloproteinase-3 (MMP-3)
32%
Mesenchymal Stem Cell-derived Exosomes
37%
Mitomycin C
55%
MMC
16%
Myofibroblast
16%
New Zealand White Rabbit
20%
Open Globe Injury
37%
Phacoemulsification
20%
Platelet-rich Fibrin
18%
Platelet-rich Fibrin Membrane
18%
Rabbit Eye
27%
Resveratrol
75%
Retinal Ganglion Cell Loss
25%
Stem Cell Secretome
17%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
20%
Trabeculectomy
56%
Transforming Growth Factor-β
53%
Treatment Group
34%
Triamcinolone Acetonide
44%
Type I Collagen
37%
Vascular Endothelial Growth Factor
23%
WJ-MSCs
25%
Wound Healing
24%
Medicine and Dentistry
Amnion
12%
Antifibrotic Agent
19%
Asiatic Acid
25%
Bevacizumab
37%
Caspase 3
18%
Cell Loss
12%
Cell Migration
12%
Clinical Examination
15%
Closed Angle Glaucoma
12%
Collagen Type 1
24%
Congenital Glaucoma
12%
Corneal Wound Healing
12%
Corpus Callosum Agenesis
12%
Curcumin
25%
Downregulation
15%
Dry Eye
12%
Endothelial Cell
12%
Extracellular Matrix
15%
Eye Disease
15%
Fibrin Glue
75%
Fibroblast
50%
Fibrosis
60%
Ganglion
12%
Glaucoma
14%
Immunohistochemistry
14%
In Vitro
13%
Interleukin 4
15%
Intraocular Pressure
17%
Keratitis
12%
Matrix Metalloproteinase
12%
Mesenchymal Stem Cell
37%
Migration Inhibition
12%
Mitomycin
42%
Ocular Surface
15%
Ophthalmology
12%
Penetrating Trauma
12%
Phacoemulsification
16%
Platelet-Rich Fibrin
25%
Pseudomonas aeruginosa
12%
Pterygium
25%
Resveratrol
25%
Strabismus Surgery
25%
Stromelysin
20%
Trabeculectomy
42%
Transforming Growth Factor Beta
27%
Treatment Group
22%
Triamcinolone Acetonide
37%
Vasculotropin
15%
Wharton Jelly
12%
Wound Healing
26%
Pharmacology, Toxicology and Pharmaceutical Science
Actin
6%
Antiapoptotic
12%
Asiatic Acid
25%
Bevacizumab
38%
Biomaterial
12%
Caspase 3
11%
Chemical Injury
12%
Collagen Type 1
12%
Cornea Injury
12%
Curcumin
12%
Dexamethasone
13%
Dry Eye
12%
Epidermal Growth Factor
12%
Eye Disease
13%
Eye Injury
6%
Fibrin Glue
37%
Fibrosis
25%
Gelatinase A
8%
Glaucoma Medication
8%
Growth Factor
6%
Inflammation
23%
Interleukin 4
15%
Intravitreal Administration
21%
Keratitis
12%
Leporidae
28%
Matrix Metalloproteinase
12%
Mitomycin
25%
Neuroprotective Agent
15%
New Zealand Rabbit
16%
Open Angle Glaucoma
12%
Penetrating Trauma
12%
Phosphate Buffered Saline
7%
Plasminogen Activator Inhibitor 1
12%
Platelet-Rich Fibrin
12%
Pseudomonas aeruginosa
12%
Pterygium
12%
Reperfusion Injury
25%
Resveratrol
37%
Scatter Factor
12%
Smooth Muscle Actin
12%
Strabismus
25%
Tissue Inhibitor of Metalloproteinase
8%
Transforming Growth Factor Beta
37%
Treatment Group
12%
Triamcinolone Acetonide
51%
Tumor Necrosis Factor
7%
Vasculotropin
25%
Vitreoretinopathy
16%
Wound
11%
Wound Healing
37%